Friday Wasn't Bad; Amazon-Induced Woes: Best of Kass

Doug Kass fills his blog on RealMoney every day with his up-to-the-minute reactions to what's happening in the market and his legendary ahead-of-the-crowd ideas. This week he blogged on:

  • How Friday had some possible positives.
  • How Amazon is inducing retail woes.

Click here for information on RealMoney, where you can see all the blogs, including Doug Kass'--and reader comments--in real time.

Some Potential Positives for Friday
Originally published Nov. 4 at 3:01 p.m. EDT
Some potential positives Friday:

  • Strength in the Russell Index.
  • Improving breadth.
  • Improving Clinton odds by "538" and the London betting parlors.
  • A great deal of pushback to my idea of a trading rally.
  • Turnaround in large-cap biotech (Allergan (AGN) , Celgene (CELG) , Gilead Sciences  (GILD) ) and speculative biotech (Intrexon (XON) , Sage Therapeutics  (SAGE) )--which had appeared to have been breaking down this week.
  • Lack of enthusiasm and general skepticism regarding the ability of today's rally to extend into next week.
  • Continued stabilization in the junk bond market.
Position: None.

Retail Woes Are Amazon-Induced
Originally published Nov. 4 at 7:58 a.m. EDT
Last week, L Brands ( LB) , a quality retailer that operates Victoria's Secret and Bath and Body Works, released a sales warning.

On Wednesday, Costco (COST) released its monthly sales, up 2%. While there are attempts to dress up a pig, the numbers were not good even though they were better than September.

If you liked this article you might like

Elizabeth Warren Slams Wells Fargo, Equifax: Cramer's Top Takeaways

Centene: Cramer's Top Takeaways

The Pitney Bowes Transformation: Cramer's Top Takeaways

Healthcare Trust of America, Marathon Petroleum: 'Mad Money' Lightning Round

How Long Can This Rally Run?: Cramer's 'Mad Money' Recap (Monday 9/19/17)